This report is being filed on an international product, list number 06r90-22 (sars-cov-2 igg) that has a similar product distributed in the us, list number 06r90-20 /-30 (sars-cov-2 igg), (b)(4).An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
|
The complaint investigation for falsely negative alinity i sars-cov-2 igg results included a search for similar complaints, and the review of complaint text, trending data, labeling, and device history records.Return testing was not performed as returns were not available.The ticket search determined normal complaint activity for the likely cause lot.Trending review determined no trends identified for the product for the issue.Clinical sensitivity and specificity testing was completed with an in-house retained kit of the complaint lot 33057ud00.All specifications were met indicating the lots are performing acceptably.Device history record was reviewed and did not identify any non-conformances or deviations.Labeling was reviewed and adequately addresses the issue under review.Based on the investigation, no systemic issue or product deficiency for alinity i sars-cov-2 igg reagent lot 33057ud00 was identified.
|